Skip to main content
. 2014 Mar 28;17(1):61–68. doi: 10.4048/jbc.2014.17.1.61

Table 1.

Characteristics of randomized controlled trials included in the present meta-analysis

graphic file with name jbc-17-61-i001.jpg

RCT=randomized controlled trials; bid=twice a day; GEM=gemcitabine; CAP=capecitabine; DOC=docetaxel; LET=letrozole.